Submitted by Anonymous (not verified) on 5 December 2025 - 9:38
Opinion/decision on a Paediatric investigation plan (PIP): Uplizna, inebilizumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Surgical and medical procedures, PIP number: EMA/PE/0000238005
Source: